Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)
about
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation.MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cellsNatural killer cell tolerance: control by self or self-control?Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiencyNatural killer cells in infection and inflammation of the lungInnate or adaptive immunity? The example of natural killer cellsKnow Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control.Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency.Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice.Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.TAP deficiency syndrome.Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence.The natural killer cell -- friend or foe in autoimmune disease?A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.A new self: MHC-class-I-independent natural-killer-cell self-tolerance.Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient PatientsClinical and immunological aspects of HLA class I deficiency.Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.Human natural killer cell development.Activation, coactivation, and costimulation of resting human natural killer cellsActivation and self-tolerance of natural killer cells.Human natural killer cells.Natural killer cells and their receptors in multiple sclerosis.Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cellsNatural killer cells in human autoimmune disordersThe role of natural killer cells in hematopoietic stem cell transplantation.Natural killer cell regulation - beyond the receptors.Single nucleotide polymorphisms in the FcγR3A and TAP1 genes impact ADCC in cynomolgus monkey PBMCs.NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model.Use of natural killer cells as immunotherapy for leukaemia.Ly49C Impairs NK Cell Memory in Mouse Cytomegalovirus Infection.Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression.High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors.Proliferative and cytotoxic response of human natural killer cells exposed to transporter associated with antigen-processing-deficient cells.The Broad Spectrum of Human Natural Killer Cell Diversity.A novel spontaneous mutation in the TAP2 gene unravels its role in macrophage survival.Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors.HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis.Moving the Cellular Peptidome by Transporters.Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors-Human Leukocyte Antigen Ligand Mismatch and Activation Receptor-Ligand Interactions.
P2860
Q24536121-E1F832FA-384C-41F6-8F80-C8D9C6945373Q26866479-E1EA7947-61F3-4C61-B986-7C1263C05F81Q27003931-B9F29912-737B-42D4-B3B6-99D683C5E637Q28347602-1F40ECEF-2CC1-4FD5-99FB-5143E796CE51Q28391714-2AA52024-429B-4786-960E-339CE870B9A6Q29615106-96427CAF-F12D-434A-ABDF-E26B206D537BQ30413217-076464DC-D39D-4176-BC2B-4C79CD6E6185Q33302895-42E79FA3-F96F-44E5-A614-74A3A818C72EQ33474773-AA158062-F6B2-42A3-A679-2995E66624D7Q33810001-7FED1C16-B196-41AA-A8C5-D99BDDFFF5A2Q33994458-923FC9D8-221D-49BC-825E-0AE42DE1A251Q34360327-44977E19-A7C3-4528-9A64-83B0CFBC9FA4Q34613914-D02FB442-022F-421F-B970-6C67498AF943Q35847508-8DA875FB-52A9-4CFA-A3D8-3D2BB949AF52Q36102621-76EAA93D-6B9C-412F-A9C3-63C780852D64Q36123419-303BFEA2-7071-4C7F-95F9-7079AC163FF9Q36222638-192C87CC-83F6-4179-BA59-AA72DAD1FC8AQ36407362-AE4C76C3-85A0-4049-9BC0-7AA0B5890D53Q36652161-2914E646-BB3C-4643-89A9-70C71A2A0841Q36652166-EABCB17E-6616-4C80-B8AF-981ACDD7842FQ36652183-DE0DF5E0-6183-4DF5-8089-5F7ADC0EFBD7Q36787596-89DF4683-F0DA-4F93-90C4-B31DD94E7C32Q37124504-DFCFEFFC-0821-4417-948B-751BD6DAFC93Q37256962-E918E38E-B653-48E6-BA05-7854CC8B9B63Q37690952-F375600F-368A-4AB0-8B89-F8FC697985BCQ37853569-35296FE3-7610-4BFD-9BCA-97E697152ED1Q38265518-D3370159-2BBA-4D86-84D7-817391FF9707Q38982760-A74F52BE-D9D0-44B2-9571-628DAB7814CDQ39864722-7F0079FE-313D-4716-A179-40EE84A6E7FCQ40047650-1F5E8024-A7FA-487C-B8F8-A90ED90C8AEBQ40656349-29425FEE-AAF5-4D76-A121-8950D651D065Q40956454-E5345B51-8D9A-4C22-8B5A-8A675047285EQ42279934-E66BD4C3-EF62-4F58-BC35-D4436F5361F1Q47210839-9A5F360D-0904-4D6B-87EB-33E1290CEA1AQ47373461-3867D542-44D7-406C-BF94-201CF513E90DQ51319062-C7E47F2A-C8A0-4768-9F26-A0D7E24BAA4DQ54549246-2EEF9289-7518-4276-AF4C-E47F9F025D5FQ54633741-45099983-BAF4-495A-822E-0C9B4ECDF16BQ55365557-1B6B7A5A-6549-438C-8030-5ACF7F03E0A6Q55419590-C437E603-1F8A-4DAF-9864-DB8EA4C8B38B
P2860
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Activity and phenotype of natu ...... pe I bare lymphocyte syndrome)
@ast
Activity and phenotype of natu ...... pe I bare lymphocyte syndrome)
@en
type
label
Activity and phenotype of natu ...... pe I bare lymphocyte syndrome)
@ast
Activity and phenotype of natu ...... pe I bare lymphocyte syndrome)
@en
prefLabel
Activity and phenotype of natu ...... pe I bare lymphocyte syndrome)
@ast
Activity and phenotype of natu ...... pe I bare lymphocyte syndrome)
@en
P2093
P2860
P356
P1476
Activity and phenotype of natu ...... pe I bare lymphocyte syndrome)
@en
P2093
P2860
P304
P356
10.1084/JEM.187.1.117
P407
P577
1998-01-01T00:00:00Z